G

Gain Therapeutics, Inc. (GANX)

NGM – Real Time Price. Currency in USD

2.17

+0.11 (5.34%)

Market open: Aug 12, 2026, 3:22 PM EDT

2.07

+0.01 (0.26%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Gain Therapeutics, Inc. (GANX)

NGM – Real Time Price. Currency in USD

2.17

+0.11 (5.34%)

Market open: Aug 12, 2026, 3:22 PM EDT

2.07

+0.01 (0.26%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

55K

140K

Cost of goods sold

-94K

-84K

-80K

-64K

Gross Profit

-94K

-84K

-25K

76K

Operating expenses (excl. COGS)

-19M

-20M

-22M

-18M

Operating Income

-19M

-20M

-22M

-18M

Non-operating income, total

-589K

476K

65K

279K

Pretax income

-19M

-20M

-22M

-17M

Equity in earnings

0

Taxes

-861K

-537K

-79K

-93K

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

-20M

-22M

-18M

Discontinued operations

0

Net income

-20M

-22M

-18M

Dilution adjustment

0

Preferred dividends

0

Search stocks

Gain Therapeutics, Inc. (GANX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Gain Therapeutics, Inc. (GANX)

Income Statement (Annual)